Skip to main content

Azenta, Inc.

corporate_fare Company Profile

Azenta, Inc.

AZTA·NASDAQ·Technology·CIK 0000933974

Azenta, Inc. is a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The company entered the life sciences market in 2011, leveraging in-house precision automation and cryogenics capabilities previously applied in semiconductor manufacturing, which led to the development of automated ultra-cold storage solutions. Since then, Azenta has expanded its life sciences offerings through internal investments and a series of acquisitions. Azenta supports customers from research and clinical development to commercialization with sample management and automated storage systems, as well as genomic services expertise. Its portfolio spans the life cycle of samples, including procurement, automated storage systems, genomic services, sample consumables, informatics and data software, and sample repository services. Customers include pharmaceutical, biotechnology and life sciences research institutions. As of September 30, 2026, Azenta employed approximately 2,850 full-time employees, part-time employees and contingent workers worldwide and had sales in approximately 87 countries. The company is headquartered in Burlington, Massachusetts, with operations in North America, Asia and Europe. Azenta was founded in 1978 and became a leading automation provider and partner to the global semiconductor manufacturing industry. It divested the last of its semiconductor businesses in February 2022 for $2.9 billion in cash and since then has operated solely as a life sciences company. On December 1, 2021, the company changed its corporate name from "Brooks Automation, Inc." to "Azenta, Inc." and its common stock began trading on the Nasdaq Global Select Market under the symbol "AZTA." In July 2026, Azenta divested its B Medical Systems business for $63.0 million in cash, simplifying its portfolio and allowing management to focus on driving revenue growth and profitability in its core Sample Management Solutions and Multiomics segments.

Azenta, Inc. (NASDAQ:AZTA) is a publicly traded company in the Technology sector. Wiseek has independently scored 23 items for AZTA at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Azenta Reports Increased Net Loss Driven by Discontinued Operations, Discloses Material Weaknesses in Internal Controls, and Authorizes New $250M Share Repurchase Program
  • Azenta Reports Mixed Q1 Results, Authorizes $250M Share Repurchase, Finalizes B Medical Systems Sale
  • Azenta Stockholders Approve 2.75M Share Increase for Equity Incentive Plan

Financial Snapshot

Fiscal year ended September 30, 2026
Revenue
$621.7M
Net Income
-$166.99M
Diluted EPS
-$3.70
Op. Cash Flow
$57.51M
Free Cash Flow
$27.43M
Gross Profit
$274.96M
Operating Income
-$174.7M
Cash & Equivalents
$193.8M
Debt / Equity
0.00×
Net Margin
-26.9%
Shares Outstanding
41.76M sh
Source: 10-K · filed 2026-11-19 · accession 0001628280-26-075072
$44.8
52-week range · as of 2026-11-19 $15.93 – $50.05
Market cap
$1.88B
Volume
621.1K (0.6× avg)
3-mo avg 995.8K
Live data · 2026-11-22 12:49 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AZTA - Filings & News (Page 2)

AZTA
Feb 05, 2026, 4:09 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $27.85
Real-time Price: $44.80 info
Change: +$16.95 (+61%) info
Market Cap: $1.879B info
AZTA
Feb 04, 2026, 7:24 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.32
Real-time Price: $44.80 info
Change: +$9.48 (+27%) info
Market Cap: $1.879B info
AZTA
Jan 29, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $39.00
Real-time Price: $44.80 info
Change: +$5.80 (+15%) info
Market Cap: $1.879B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets